Navigation Links
PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts) from Arcturus, now part of Molecular Devices

ProductsPixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts) from Arcturus, now part of Molecular Devices
Company Arcturus, now part of Molecular Devices
Item PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (220 volts)
Price 
Description Obtain Clean and Accurate Results

Laser Capture Microdissection (LCM) enables you to dramatically increase the sensitivity and accuracy of molecular assays by starting with samples of homogeneous cell types and multi-cellular structures isolated from whole tissue or cytology samples. This unique approach to microdissection-developed in 1996 at the National Institutes of Health and available exclusively from Arcturus-ensures that biological molecules such as RNA and DNA, remain undamaged during the microdissection process. Downstream molecular analysis of these molecules produces accurate and assured results that have led to over 300 peer-reviewed publications by independent researchers.

Use with All Fixed Tissue and Cell Preparations

LCM has enormous flexibility with respect to tissue and cell fixation preparations. LCM effectively extracts cells from both paraffin-embedded and frozen tissue sections prepared using a wide variety of different dyes, slide surfaces, and protocols.

Isolate Cells of Interest Quickly and Conveniently

LCM utilizes a low-power infrared laser to melt a special thermoplastic film over the cell(s) of interest. Especially developed CapSure HS or CapSure Macro Caps that are coated with this thermoplastic film are placed on the tissue section or cytology sample. The PixCell IIe LCM instrument is then used to direct the laser through the cap to melt the film onto the cells of interest. When you lift the cap, the selected cells remain attached and are captured for further analysis.

Info Arcturus, now part of Molecular DevicesArcturus, now part of Molecular Devices
400 Logue Avenue
Mountain View, CA 94043, USA
Customer Service: 650.962.3020
Fax Number: 650.962.3039
Web Site: http://www.arctur.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PixCell IIe LCM Instrument with PixCell II Image Archiving Workstation (110 volts) from Arcturus, now part of Molecular Devices
2. Full-Configuration Camera Link NI PCIe-1429 from National Instruments Corporation
3. Bio-Stack Twister II Microplate Handler from BioTek Instruments
4. ELx50 Microplate Strip Washer from BioTek Instruments
5. Bio-Stack Microplate Stacker from BioTek Instruments
6. DMWB3-223ASC Digital Compound DIN from Motic Instruments, Inc.
7. DMWB1-223ASC Digital Compoud DIN from Motic Instruments, Inc.
8. Precision XS Microplate Sample Processor from BioTek Instruments
9. Synergy HT Multi-Detection Microplate Reader from BioTek Instruments
10. RapidCycler 2 Instrument from Idaho Technology Inc.
11. DMW-143 FBGG Digital Stereo Zoom from Motic Instruments, Inc.
... Dawbarn and S.J. Allen (1995) ... by world authorities on current issues relating ... disease. Several major advances have been made ... this disease. Topics include molecular neuropathology through ...
Normal human serum, single donor...
Cytidine 5'-Triphosphate, Sodium (CTP), 1 g. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
biotin-4-fluorescein...
Biology Products:
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/11/2015)... 2015 Curemark LLC, a privately held drug ... new Phase III double blind, randomized, placebo-controlled clinical trial ... on all children ages 3-8 with Autism. Previously, Curemark ... double blinded clinical trial for CM-AT in children ages ... digestive enzyme chymotrypsin. This new trial will help determine ...
(Date:5/7/2015)... May 7, 2015 Fingerprint ... FPC1022 and FPC1035, FPC,s smallest touch fingerprint sensors ... mainly considered for integration on the backside of ... OEMs increased possibilities to integrate touch fingerprint sensors ... also improves possibilities for module manufacturers to customize ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... Associate Professor Catherine Pickering, said the Griffith study looked ... can be dispersed through horse manure. The findings have ... Restoration . "We reviewed 15 studies on seed ... North America, three from Australia and one study each ...
... , Nov. 7, 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: ... its ongoing Phase 1 trial of KB004, an anti-EphA3 ... session at the 55 th American Society of ... trial of KB004 is a multi-center, dose-escalation study evaluating ...
... 7, 2013 The knowledge and skills required to change ... to those living with financial limitations. Competing demands on ... better diets. However, two researchers at the University ... the effects that three educational sessions might have on ...
Cached Biology News:Saddling up against the threat to our National Parks 2KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 2KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 3KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 4KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 53 'hands on' nutrition classes -- Enough to impact health behaviors in lower income women 2
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... that develops and commercializes proprietary technologies and products for ... results for the second fiscal quarter ended March 31, ... continued to advance business with our existing customers and ... President and CEO of SQI. "The delivery of a ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 uBiome, ... announced a partnership with PicnicHealth, a healthcare company ... Participants diagnosed with Inflammatory Bowel Disease (IBD) will ... a complementary uBiome research kit. Both companies were ... , For more information on this ...
(Date:5/21/2015)... 21, 2015  CytRx Corporation (NASDAQ: CYTR ... in oncology, today announced positive updated results from ... for the treatment of unresectable glioblastoma multiforme (GBM), ... multisite trial is designed to investigate the preliminary ... tumors have progressed following prior treatment with surgery, ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2